Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

NCT00728455 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Metabolism and Nutrition Disorder
Obesity

Interventions

DRUG: NNC 0070-0002-0349
DRUG: NNC 0070-0002-0349
DRUG: NNC 0070-0002-0349
DRUG: NNC 0070-0002-0349
DRUG: NNC 0070-0002-0349
DRUG: placebo
DRUG: placebo
DRUG: placebo
DRUG: placebo
DRUG: placebo

Sponsor

Novo Nordisk A/S